- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01764282
Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission
August 24, 2017 updated by: National Center for AIDS/STD Control and Prevention, China CDC
A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission
The purpose of this study is to evaluate the effectiveness of reducing HIV transmission among sero-discordant couples by applying comprehensive intervention components.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A cluster-randomized controlled trial was carried out in forty counties from 16 cities.
The strategy of Social Marketing was applied to influence sero-discordant couples' behavioral changes including safer sexual intercourses, regular HIV testing for the negative partners, antiretroviral therapy initiation.
Study Type
Interventional
Enrollment (Actual)
11096
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangxi
-
Nanning, Guilin, Laibin, Qinzhou, Guangxi, China, 530028
- Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region
-
-
Henan
-
Zhumadian, Henan, China, 463000
- Center for Disease Control and Prevention, Henan Province
-
-
Sichuan
-
Liangshan, Sichuan, China, 615000
- Center for Disease Control and Prevention, Sichuan Province
-
-
Xinjiang
-
Urumchi, Ili, Xinjiang, China, 830002
- Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region
-
-
Yunnan
-
Kunming, Dehong, Wenshan, Honghe, Yunnan, China, 650022
- Center for Disease Control and Prevention, Yunnan Province
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 59 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Couples are required to have a stable relationship and live together in the last 3 months;
- Older than 18 years and younger than 60 years; without regard to CD4 count;
- Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment will be included during the study period).
Exclusion Criteria:
- Couples are not have a stable relationship or do not live together in the last 3 months;
- Younger than 18 years old.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
comprehensive intervention components
|
ART promotion, Couple testing and consulting promotion, and Condom use promotion
|
No Intervention: Usual
According the National HIV Antiretroviral treatment Guideline, provide treatment referrals for those treatment-eligible HIV-positive patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HIV seroconversion rate of HIV negatives among HIV serodiscordant couples
Time Frame: up to 2 years
|
up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of HIV positives receiving ART among HIV serodiscordant couples
Time Frame: up to 2 years
|
up to 2 years
|
The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couples
Time Frame: up to 2 years
|
up to 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Zuyou Wu, MD, PHD, National Center for AIDS/STD Control and Prevention, China CDC
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011 Jul;11(7):516-24. doi: 10.1016/S1473-3099(11)70097-4.
- Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010 May 15;50 Suppl 3(0 3):S85-95. doi: 10.1086/651478.
- Stephenson R, Barker J, Cramer R, Hall MA, Karita E, Chomba E, Vwalika C, Allen S. The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia. AIDS Care. 2008 Mar;20(3):395-405. doi: 10.1080/09540120701593497.
- He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, Yang Y, Wang J, Montaner JS, Wu Z; China National HIV Prevention Study Group. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013 Nov 13;8(11):e77981. doi: 10.1371/journal.pone.0077981. eCollection 2013.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
December 31, 2015
Study Completion (Actual)
December 31, 2015
Study Registration Dates
First Submitted
December 26, 2012
First Submitted That Met QC Criteria
January 7, 2013
First Posted (Estimate)
January 9, 2013
Study Record Updates
Last Update Posted (Actual)
August 25, 2017
Last Update Submitted That Met QC Criteria
August 24, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 2012ZX10001007-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on comprehensive intervention components
-
Mukoviszidose Institut gGmbHHannover Medical School; Goethe University; Federal Ministry of Health, Germany; Wuerzburg University Hospital and other collaboratorsCompleted
-
Nanjing Medical UniversityCompleted
-
University Hospital, GrenobleCompleted
-
University of GuelphCompleted
-
The University of Tennessee, KnoxvilleTerminatedBreast Cancer | Sedentary LifestyleUnited States
-
The University of Tennessee, KnoxvilleActive, not recruiting
-
Samsung Medical CenterActive, not recruitingLung CancerKorea, Republic of
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID); Ministry of Health... and other collaboratorsCompletedDepression | Anxiety | Post-Traumatic Stress DisorderIraq
-
Duke-NUS Graduate Medical SchoolNot yet recruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting